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Results: The use of increased activity seeds significantly 
reduces needle number. This impact can be seen more with 
larger prostate volumes; with an average reduction of 6 
needles per patient. Prostate dose stats shows a slightly 
higher average dose is achieved to prostate (D90 high-149.8Gy 
(99.4-178.2) against D90 low-147.5Gy (100.39-177.28)) as well 
as rectum (D2cc high-121.8Gy (62.1-189.27) D2cc low-116.3Gy 
(71.26-181.75) and bladder (D2cc high-84.0Gy (55.4-148.3) D2cc 
low-84.6Gy (44.29-135.94)), however the increase in dose is 
unlikely to be clinically significant. The amount of patients 
that fall outside of the recommended constraints following 
post implant scan is the same in both high and low activity 
cases. 
 
Conclusions: Whilst a decrease in seed number is easy to 
predict when utilising higher activity seeds to achieve the 
same total activity for an implant, a less obvious relationship 
exists in needle number reduction. Needle number 
particularly peri-urethral needles have been shown to be 
associated with increased urinary-tract toxicity, by 
conservatively increasing activity of I-125 seeds it could be 
theorised that there will be a decrease in trauma associated 
LUTS while maintaining coverage and meeting OAR 
constraints. 
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Purpose/Objective: According to preoperative prostate 
volume, nomograms in low dose rate (LDR) permanent 
prostate brachytherapy allow to estimate the number and 
activity of seeds required for an interstitial implant 
procedure. Our purpose is to study the quantity of needles 
and connectors employed in manual afterloading stranded 
seed implants and to find similar relationships with pre-
implant prostate size. It would optimize ordering and using of 
material. 
Materials and Methods: We have registered 150 125I-LDR 
interstitial prostate implants with ProlinkTM service, 
QuickLinkTM delivery system (C. R. Bard, Inc.) and VariSeed™ 
v.8.0.2 treatment planning system (Varian Medical Systems, 
Palo Alto, CA, USA). Each of their needle charge scheme has 
been reviewed for the following counting: number of seeds 
(#Seeds), 5.5 mm standard SourceLinkTM connectors (A), 5.0 
mm extension connectors (B), 0.5 mm seed-to-seed 
connectors (C) and quantity of needles used (N). Intra- and 
preoperative prostate volume were also annotated (Vintra and 
Vpre). We have used Stata® v12.0 software for data analysis. 
We have carried out a retrospective ordering simulation 
taking into account available commercial cartridges of 
connectors in order to test the applicability of the formulae 
obtained.  
Results: Connectors data registered for each implant 
procedure are plotted in the next figure: 
 
 
 
Total connectors sums (A+B+C) are highly correlated with 
#Seeds (Pearson correlation coefficient r=0.90) and when 
using SourceLinkTM system, because of the needle assembly, 
every implant obeys the rule: 
 
 
Considering that B vs.Vintra follows a linear relationship it 
could then be upper bounded through the 95% confidence 
level interval superior limits of the regression coefficient and 
constant: 
 
 
Other linear regressions also suitable were: 
 
 
 
 
We took a N mean value of 16.5 needles (little variation 
along prostate volume range). Finally, solving expressions in 
terms of Vpre and #Seeds (can be defined pre-operatively by 
nomograms): 
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Simulation phase: given the statistical nature of these 
relationships, we reserved one cartridge of each connectors 
type to assure that we would not run out of them when the 
surgical procedure took place. A retrospectively application 
of these formulae yielded that we would had used only those 
corresponding A, B, C reserved cartridges in 14%, 19% and 
12% of the procedures. We would have had only to add that 
spent cartridge when placing the following order. 
Conclusions: When LDR-brachytherapy seeds implant with 
needle loading on demand technique is used the quantity of 
the different types of seed connectors can be statistically 
expressed in terms of the preoperative prostate volume. With 
enough experience in the implant technique and preoperative 
prostate volumetric study it is possible to mark out 
institution-specific bounds to each of these quantities. It 
optimizes the preoperative prediction of seeds connectors, 
seeds and needles that will be used and reduces costs in 
material and storage.  
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Purpose/Objective: To analyze the twelve years outcomes of 
I-125 LDR brachytherapy in Turkish men with low-
intermediate risk localized prostate cancer.  
Materials and Methods: Between 2000-2004, 139 patients 
treated with LDR brachytherapy were analyzed 
retrospectively. Brachytherapy was monotherapy in 127 
pts.and used with external beam radiotherapy in 12 pts. Four 
pts excluded from study due to protocol deviation. 135 pts 
were analyzed for disease control and survival. For all the pts 
preplanning was done in treatment conditions. During the 
aplication real time planning was used. Four- six weeks after 
application postplanning dosimetry was done with CT and MR 
images. In dosimetry D90, V100, V150, V200, V250 for 
prostate; V100, V150 for urethra ; V100, dose at 4 cc for 
rectum were evaluated. Survival curves were calculated using 
the Kaplan- Meier method, and the significance was 
calculated by the log-rank test. To compare the prognostic 
factors Chi- square test was used.  
Results: The median follow-up time was 88 months ( 6-170 
months). The median age of 135 pts. Was 65 years (44-81 
years). In pts 64.4 % of them were in low risk and 35.6 % in 
intermediate risk. The mean PSA value at diagnosis was 8,12 
ng/ml (SD ±6,33). In 43.2 % of the pts received androgen 
deprivation for 3 months before procedure . T stages were 
T1c in 12 pts, T2a in 64 pts, T2b in 53 pts and T3 in 6 pts. 
During procedure median 28 (18-35) needles and 85 (65-110) 
seeds at 0.49 U/seed(0.43-0.50) were used. Prescribed dose 
was set at 145 Gy in monotherapy and 110 Gy in combined 
treatment. Treatment results were given in table 1.  
 
 
 
Conclusions: Our results are in concordance and comparable 
with other reports on I-125 LDR prostate brachytherapy. 
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Purpose/Objective: To analyze efficacy and toxicity profile 
of intestinal HDR brachytherapy in rectal Adenocarcinoma 
patients after tumorectomy as a salvage treatment. 
Materials and Methods: Between April 2009 and July 2014 15 
patients (pts) with adenocarcinoma underwent conformal 
HDR brachytherapy (HDR-BRT) with a temporary intestinal 
implants (2-7 catheters). The mean age of pts was 70,47 ( 
range 45-87). Twelve of patients received 30 Gy in 5 days (3 
Gy per fraction) twice daily. One patient received 24 Gy in 6 
days (4 Gy per fraction). One patient received 10 Gy in single 
fraction. One patient received 15 Gy in five days (3 Gy per 
